Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local tranexamic acid versus placebo for dry socket prevention after mandibular impacted wisdom tooth surgery
IRCT20120215009014N313Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alveolar osteitis (AO) and impacted third molar (I3M) comparing Local tranexamic acid with Placebo (2 arms). Primary endpoints: Severity of pain, Elimination of blood clots and 2 more. Started Jan 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
alveolar osteitis (AO)impacted third molar (I3M)
Beyond the preview
Go deeper on IRCT20120215009014N313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N313.